Skip to main content
menu

August 2016

Boot Camp Gets Early Stage Faculty Off on the Right Foot

Boot Camp Gets Early Stage Faculty Off on the Right Foot

Register now for the Early Stage Faculty Boot Camp (formerly the Academic Core Curriculum for Junior Faculty), which will be held September 25 through 29. Interested faculty should register by September 1.

BUILDing Diversity in Clinical Trials through Collaborations

BUILDing Diversity in Clinical Trials through Collaborations

Researchers from URMC and Xavier University have developed a collaboration through the BUilding Infrastructure Leading to Diversity (BUILD) network to improve diversity in cancer clinical trials. The group aims to raise researchers’ cultural competency and educate underrepresented populations about the importance of participating in clinical trials.

The Legacy of Tuskegee

The Legacy of Tuskegee

Forty-six years have passed since the whistle was blown on the Tuskegee syphilis experiment for its unethical treatment of poor Black men in Alabama, but a research suggests its the study has had long-lasting effects on the health of Black and African American men. 

Former KL2 Scholar Honored as Brilliant New Investigator

Former KL2 Scholar Honored as Brilliant New Investigator

Past KL2 scholar, Feng (Vankee) Lin, PhD, RN, is set to receive the Brilliant New Investigator Award from the Council for the Advancement of Nursing Science (CANS) this fall. Lin is an early stage investigator in the UR School of Nursing who has demonstrated extraordinary potential to have a significant impact on the science and practice of nursing and health care.

Find Research Participants Using Tools on the New Health Research Website

Find Research Participants Using Tools on the New Health Research Website

The UR CTSI offers many resources for investigators who conduct research involving human subjects, including access to local and national research participant registries. These online databases help match investigators with healthy volunteers and patients with specific illnesses who are interested in participating in clinical trials.